Knowledge Center 

In wall poster format, this study captures how Capsugel's Xcelodose 600 filling machine works with blended products. Complete with methods, results, diagrams, a conclusion and acknowledgements.

This article, published in 2010 in Future Science, Ltd., details the methodologies involved in dosing Dry Powder Inhalers (DPIs) such as micro-dosing and the "pepper pot" principle. It also covers Capsugel's Xcelodose™ System for DPIs.

Iain McGilverary of McGilveray Pharmacon discusses implications of the Biopharmaceutical Classification System for drug policies, regulations, and approval processes at the Controlled Release Society symposium sponsored by Capsugel.

What drugs are best suited to survive? This article outlines a time-saving technique for filling capsules using pure drug or API micro-dosing rather than blended products for production.

Dr. O. Helen Chan 's remarks on the potential barriers to oral bioavailability in formulations at a Hong Kong symposium; she addresses the bioequivalency of pregabalin and the stability of gabapentin.

Symposia remarks (Tokyo, 1997) on the theoretical principles of bioequivalence, in vitro dissolution, bioavailability and the ongoing use of the Biopharmaceutic Drug Classification system.

The best way to blind drugs during clinical trials is with overencapsulation. Robert Meyers and Colleen Cratty look at the best methods for overencapsulation in this "Pharmaceutical Engineering" (2003) article.

Closed loop micro-dosing is an issue in the development phase of capsule production that can be overcome with accurate, API dose dispensing. This article discusses rates, variability and other metrics involved in this process.

Complete with detailed charts and specs, this brochure is a guide to colorants status for 80 countries. Produced by Capsugel for marketing.

A Capsugel brochure about the advantages of the Licaps capsule to address challenges with poorly soluable drug compounds.